Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Surface OncologyDyadic InternationalBIONDVAX PHARMA/SLogicBio TherapeuticsErytech Pharma
SymbolNASDAQ:SURFNASDAQ:DYAINASDAQ:BVXVNASDAQ:LOGCNASDAQ:ERYP
Price Information
Current Price$4.89$6.04$19.90$6.86$8.63
52 Week RangeBuyBuyN/ABuyBuy
Beat the Market™ Rank
Overall Score0.71.30.51.41.2
Analysis Score0.03.50.03.53.5
Community Score2.62.32.42.32.1
Dividend Score0.00.00.00.00.0
Ownership Score1.00.00.01.00.0
Earnings & Valuation Score0.00.60.00.00.6
Analyst Ratings
Consensus RecommendationBuyBuyN/ABuyBuy
Consensus Price TargetN/A$12.50N/A$20.00$13.00
% Upside from Price TargetN/A106.95% upsideN/A191.55% upside50.61% upside
Trade Information
Market Cap$132.83 million$165.91 million$134.43 million$159.07 million$152.49 million
Beta2.090.431.971.552.67
Average Volume1,231,506256,093113,56449,5562,963
Sales & Book Value
Annual Revenue$15.36 million$1.68 millionN/AN/AN/A
Price / Sales9.0298.76N/AN/AN/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$2.88 per share$1.25 per share($1.27) per share$1.45 per share$5.34 per share
Price / Book1.704.83N/AN/AN/A
Profitability
Net Income$-54,790,000.00$-8,310,000.00$-23,410,000.00$-40,130,000.00$-70,180,000.00
EPS($1.97)($0.31)N/A($1.78)($3.92)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/A27.45N/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-70.90%-523.65%N/AN/AN/A
Return on Equity (ROE)-38.44%-22.87%N/A-86.99%N/A
Return on Assets (ROA)-20.13%-22.05%-109.31%-69.95%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.43%N/AN/A0.29%0.15%
Current Ratio6.97%28.89%25.14%8.95%4.10%
Quick Ratio6.97%28.89%25.14%8.95%4.09%
Ownership Information
Institutional Ownership Percentage48.24%12.90%6.21%47.91%7.44%
Insider Ownership Percentage33.00%23.90%6.03%23.40%N/A
Miscellaneous
Employees7661423172
Shares Outstanding28.32 million27.47 million6.54 million23.32 million17.94 million
Next Earnings Date8/5/2020 (Estimated)8/11/2020 (Estimated)6/4/2020 (Estimated)8/11/2020 (Estimated)N/A
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.